Bard Logo

Investor Relations

Webcast ImageWebcast
Q2 2015 C. R. Bard, Inc. Earnings Conference Call (Live)
07/23/15 at 5:00 p.m. ET
Q2 2015 C. R. Bard, Inc. Earnings Conference Call
Thursday, July 23, 2015 5:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
BCR (Common Stock)
ExchangeNYSE (US Dollar)
Price$171.30
Change (%) Stock is Down 1.47 (0.85%)
Volume339,746
Data as of 07/02/15 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Featured Reports
Download Documentation2015 Proxy Statement
Download Documentation2014 Annual Report
Related Links
Corporate Governance
Contact the Bard Board of Directors
Recent NewsMore >>
DateTitle 
07/01/15Bard to Host Earnings Conference Call on July 23, 2015
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 1, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Thursday, July 23, 2015 at 5:00 PM EDT, to discuss the company’s second quarter 2015 operating results, and to provide financial guidance for the third quarter of 2015. Bard is scheduled to issue an earnings press release after the market closes on July 23, 2015. A live audio webcast of Bard's investor conference w... 
Printer Friendly Version
06/25/15 The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 25, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced the publication of results from the LEVANT 2 study in the June 24, 2015 online issue of The New England Journal of Medicine. Results from LEVANT 2 demonstrated superior primary patency for Lutonix® 035 Drug Coated Balloon PTA Catheter (Lutonix® DCB) over standard percutaneous transluminal angioplasty (PTA), as well as safety consistent with standard PTA... 
Printer Friendly Version
06/10/15Bard Announces $500 Million Share Repurchase Authorization
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 10, 2015-- The Board of Directors of C. R. Bard, Inc. (NYSE: BCR) today authorized the repurchase of up to $500 million of the company’s common stock. This is in addition to approximately $160 million remaining under the prior authorization announced in June 2014. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions. C. R. Bard, Inc. (www.c... 
Printer Friendly Version
06/10/15Bard Increases Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 10, 2015-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today increased the quarterly dividend on Bard's common stock by 9 percent, to 24 cents per share. The dividend is payable on July 31, 2015 to shareholders of record at the close of business on July 20, 2015. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and ma... 
Printer Friendly Version
Selected SEC Filings
Filing DateForm
04/24/1510-Q Download SEC Filing to Adobe PDF Download XBRL Content
02/18/1510-K Download SEC Filing to Adobe PDF Download XBRL Content
10/23/1410-Q Download SEC Filing to Adobe PDF Download XBRL Content
07/25/1410-Q Download SEC Filing to Adobe PDF Download XBRL Content
04/23/1410-Q Download SEC Filing to Adobe PDF Download XBRL Content
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever C. R. Bard, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.